Should I have had an SNLB?

This topic has 12 replies, 3 voices, and was last updated 9 years, 1 month ago by Mkelley1.

Post

- March 10, 2016 at 2:00 pm
- Quote
Mkelley1
Participant
One yeah ago I had a melanoma removed. .63mm/non ulcerated/2mitosis per square/Clarks level 2/located on back/ male 30 years old/ clear margins. The doctors decided not to do a SNLB because my depth was under .75 so the likelihood of a positive SNLB was low. I was staged at 1b. My question to everyone is should they have done a SNLB? It should be noted that I did have a Castle Biosciences Melanoma test and it categorized me as low risk. This test is approved and all stage 1 and 2 patients should try to get this test to help further generations of patients. They have approximately 600 patients with known 5 year outcomes and their stay is holding up well. Please let me hear your guys thoughts -Mark

Viewing 5 reply threads

Replies

- - March 10, 2016 at 9:55 pm
  - Quote
  jodaro
  Participant
  Based on my similar experience (.75mm, Stage 1b upper back/neck area) late last year and subsequent frantic Googling, it sounds like .76mm or less with lower mitotic rate doesn't indicate a SLNB, so your doctor probably did the right thing.
  
  Good to hear that test shows you as low risk. I haven't done anything like that yet, but I have a checkup appointment soon so I'll bring it up.
- - March 10, 2016 at 9:55 pm
  - Quote
  jodaro
  Participant
  Based on my similar experience (.75mm, Stage 1b upper back/neck area) late last year and subsequent frantic Googling, it sounds like .76mm or less with lower mitotic rate doesn't indicate a SLNB, so your doctor probably did the right thing.
  
  Good to hear that test shows you as low risk. I haven't done anything like that yet, but I have a checkup appointment soon so I'll bring it up.
  - March 12, 2016 at 8:18 am
    
    Quote
    Mkelley1
    Participant
    
    I have a very similar diagnosis to myself. We should talk about this offline if u are available. I would like to hear what they are doing for your treatment. -Mark- [email protected]
  - March 12, 2016 at 8:18 am
    
    Quote
    Mkelley1
    Participant
    
    I have a very similar diagnosis to myself. We should talk about this offline if u are available. I would like to hear what they are doing for your treatment. -Mark- [email protected]
  - March 12, 2016 at 8:18 am
    
    Quote
    Mkelley1
    Participant
    
    I have a very similar diagnosis to myself. We should talk about this offline if u are available. I would like to hear what they are doing for your treatment. -Mark- [email protected]
- - March 10, 2016 at 9:55 pm
  - Quote
  jodaro
  Participant
  Based on my similar experience (.75mm, Stage 1b upper back/neck area) late last year and subsequent frantic Googling, it sounds like .76mm or less with lower mitotic rate doesn't indicate a SLNB, so your doctor probably did the right thing.
  
  Good to hear that test shows you as low risk. I haven't done anything like that yet, but I have a checkup appointment soon so I'll bring it up.
- - March 12, 2016 at 11:43 am
  - Quote
  JC
  Participant
  I tried to get the DecisionDX-Melanoma‏ test done but Castle said since the focus of my tumor was extremely small and the proporation of tumor cells was no more than 30%, their type of analysis would need more tumor tissue. . insufficient specimen quantity.
- - March 12, 2016 at 11:43 am
  - Quote
  JC
  Participant
  I tried to get the DecisionDX-Melanoma‏ test done but Castle said since the focus of my tumor was extremely small and the proporation of tumor cells was no more than 30%, their type of analysis would need more tumor tissue. . insufficient specimen quantity.
- - March 12, 2016 at 11:43 am
  - Quote
  JC
  Participant
  I tried to get the DecisionDX-Melanoma‏ test done but Castle said since the focus of my tumor was extremely small and the proporation of tumor cells was no more than 30%, their type of analysis would need more tumor tissue. . insufficient specimen quantity.
  - March 27, 2016 at 9:16 pm
    
    Quote
    Mkelley1
    Participant
    
    That sounds like good news. What was your original pathology. Mitosis? Ulceration? Depth?
  - March 27, 2016 at 9:16 pm
    
    Quote
    Mkelley1
    Participant
    
    That sounds like good news. What was your original pathology. Mitosis? Ulceration? Depth?
  - March 27, 2016 at 9:16 pm
    
    Quote
    Mkelley1
    Participant
    
    That sounds like good news. What was your original pathology. Mitosis? Ulceration? Depth?

Viewing 5 reply threads

You must be logged in to reply to this topic.

I tried to get the DecisionDX-Melanoma‏ test done but Castle said since the focus of my tumor was extremely small and the proporation of tumor cells was no more than 30%, their type of analysis would need more tumor tissue. . insufficient specimen quantity.

I tried to get the DecisionDX-Melanoma‏ test done but Castle said since the focus of my tumor was extremely small and the proporation of tumor cells was no more than 30%, their type of analysis would need more tumor tissue. . insufficient specimen quantity.

I tried to get the DecisionDX-Melanoma‏ test done but Castle said since the focus of my tumor was extremely small and the proporation of tumor cells was no more than 30%, their type of analysis would need more tumor tissue. . insufficient specimen quantity.

About the MRF Patient Forum

Popular Topics

Should I have had an SNLB?

I tried to get the DecisionDX-Melanoma‏ test done but Castle said since the focus of my tumor was extremely small and the proporation of tumor cells was no more than 30%, their type of analysis would need more tumor tissue. . insufficient specimen quantity.

I tried to get the DecisionDX-Melanoma‏ test done but Castle said since the focus of my tumor was extremely small and the proporation of tumor cells was no more than 30%, their type of analysis would need more tumor tissue. . insufficient specimen quantity.

I tried to get the DecisionDX-Melanoma‏ test done but Castle said since the focus of my tumor was extremely small and the proporation of tumor cells was no more than 30%, their type of analysis would need more tumor tissue. . insufficient specimen quantity.

About the MRF Patient Forum

Popular Topics

Topic Tags